Dental Treatment Safe for Pregnant Women

Essential Dental Treatment Safe for Pregnant Women,
Says New Study in ADA Journal


Pregnant women can safely undergo essential dental treatment and receive topical and local anesthetics at 13 to 21 weeks gestation, says a study published in the June issue of The Journal of the American Dental Association.

Although obstetricians generally consider dental care safe for pregnant women, supporting clinical trial evidence has been lacking. To address this issue, researchers compared safety outcomes from the Obstetrics and Periodontal Therapy Trial in which pregnant women received scaling and root planing (deep cleaning) and essential dental treatment (defined as treatment of moderate-to-severe cavities or fractured or abscessed teeth).

The researchers randomly assigned 823 pregnant women with periodontitis to receive scaling and root planing, either at 13 to 21 weeks’ gestation or up to three months after delivery. (Experts recommend that pregnant women defer elective care before eight weeks’ gestation and during late pregnancy.) The researchers determined that 483 of these women also needed essential dental treatment. Three hundred fifty-one of the women completed all recommended treatment.

Throughout the trial, obstetric nurses reviewed medical records to monitor subjects for serious adverse events. The authors defined these events as pregnancies that ended in a nonlive birth and other adverse events that did not result in pregnancy termination (including hospitalizations for more than 24 hours because of labor pains, hospitalizations for any other reason, fetal or congenital anomalies and neonatal deaths).

The results of the study showed that “periodontal treatment and essential dental treatment, administered at a time between 13 and 21 weeks’ gestation, did not significantly increase the risk of any adverse outcome evaluated,” the authors write. “Use of topical and local anesthetics for scaling and root planing also was not associated with an increased risk of experiencing these adverse events and outcomes.”